Page last updated: 2024-08-24

gemcitabine and pf 3512676

gemcitabine has been researched along with pf 3512676 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Au, JSK; Benner, RJ; Blasinska-Morawiec, M; Ingrosso, A; Jassem, J; Krzakowski, M; Manegold, C; Meech, SJ; Readett, D; Serwatowski, P; Szczesna, A; Tan, EH; Thatcher, N; van Zandwijk, N; Zatloukal, P	1

Trials

1 trial(s) available for gemcitabine and pf 3512676

Article	Year
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Oligodeoxyribonucleotides; Proportional Hazards Models	2012

Article

Year

A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Oligodeoxyribonucleotides; Proportional Hazards Models

2012